En el Endotip Nº 2 pasaremos a revisar diferentes tópicos sobre el Síndrome Cardio Renal: Fisiopatología, Biomarcadores, Objetivos del tratamiento y Manejo Farmacológico. El análisis, resumen y presentación estuvo a cargo de la Dra. Ada Cascone, Residente del Postgrado de Medicina Interna del Hospital Domingo Luciani en Caracas.
- Does cardiovascular protection translate into renal protection? Ruiz-Hurtado G, Ruilope LM. Nat Rev Cardiol. 2014 Dec;11(12):742-6. PDF
- Cardiorenal syndrome–current understanding and future perspectives. Braam B, Joles JA, Danishwar AH, Gaillard CA. Nat Rev Nephrol. 2014 Jan;10(1):48-55. PDF
- Cardiorenal syndrome: a cardiologist’s perspective of pathophysiology. Anand IS. Clin J Am Soc Nephrol. 2013 Oct;8(10):1800-7. PDF
- Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.Guazzi M, Gatto P, Giusti G, Pizzamiglio F, Previtali I, Vignati C, Arena R. Int J Cardiol. 2013 Nov 30;169(6):379-84. PDF
- Biomarkers in cardiorenal syndromes. Tan K, Sethi SK. Transl Res. 2014 Aug;164(2):122-34. PDF
- Novel renal biomarkers to assess cardiorenal syndrome. Brisco MA, Testani JM. Curr Heart Fail Rep. 2014 Dec;11(4):485-99 PDF
- Biomarkers and physiopathology in the cardiorenal syndrome.
Bouquegneau A, Krzesinski JM, Delanaye P, Cavalier E. Clin Chim Acta. 2015 Mar 30;443:100-7 PDF - Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Hatamizadeh P, Fonarow GC, Budoff MJ, Darabian S, Kovesdy CP, Kalantar-Zadeh K. Nat Rev Nephrol. 2013 Feb;9(2):99-111 PDF
